GB1567911A - 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone - Google Patents
5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone Download PDFInfo
- Publication number
- GB1567911A GB1567911A GB36997/76A GB3699776A GB1567911A GB 1567911 A GB1567911 A GB 1567911A GB 36997/76 A GB36997/76 A GB 36997/76A GB 3699776 A GB3699776 A GB 3699776A GB 1567911 A GB1567911 A GB 1567911A
- Authority
- GB
- United Kingdom
- Prior art keywords
- imidazolidinone
- indol
- ylmethylene
- dimethyl
- methylimino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- GXBMTEAMDOVNLO-UHFFFAOYSA-N 5-(1h-indol-3-ylmethylidene)-1,3-dimethyl-2-methyliminoimidazolidin-4-one Chemical compound CN1C(=NC)N(C)C(=O)C1=CC1=CNC2=CC=CC=C12 GXBMTEAMDOVNLO-UHFFFAOYSA-N 0.000 title description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- XVVSBYAGYRRHBW-UHFFFAOYSA-N 1,3-dimethyl-2-methyliminoimidazolidin-4-one Chemical compound CN=C1N(C)CC(=O)N1C XVVSBYAGYRRHBW-UHFFFAOYSA-N 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- OLNJUISKUQQNIM-UHFFFAOYSA-N indole-3-carbaldehyde Chemical compound C1=CC=C2C(C=O)=CNC2=C1 OLNJUISKUQQNIM-UHFFFAOYSA-N 0.000 claims description 7
- 238000009833 condensation Methods 0.000 claims description 6
- 230000005494 condensation Effects 0.000 claims description 6
- NQLHETVWDMRIPV-UHFFFAOYSA-N 2-imino-1,3-dimethylimidazolidin-4-one Chemical compound CN1CC(=O)N(C)C1=N NQLHETVWDMRIPV-UHFFFAOYSA-N 0.000 claims description 4
- MHWPCWKTMIKEKJ-UHFFFAOYSA-N 4,4-dimethyl-2-(methylamino)-1h-imidazol-5-one Chemical compound CNC1=NC(C)(C)C(=O)N1 MHWPCWKTMIKEKJ-UHFFFAOYSA-N 0.000 claims description 4
- -1 alkali metal salt Chemical class 0.000 claims description 4
- 230000001430 anti-depressive effect Effects 0.000 claims description 4
- 239000000935 antidepressant agent Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000012022 methylating agents Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 229940005513 antidepressants Drugs 0.000 claims description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical group IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical class [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims description 2
- 150000007933 aliphatic carboxylic acids Chemical group 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000011987 methylation Effects 0.000 claims description 2
- 238000007069 methylation reaction Methods 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 150000003335 secondary amines Chemical class 0.000 claims description 2
- 150000003512 tertiary amines Chemical class 0.000 claims description 2
- BNGKQWIJWSOEQM-UHFFFAOYSA-N 2-(methylamino)-1,4-dihydroimidazol-5-one Chemical compound CNC1=NCC(=O)N1 BNGKQWIJWSOEQM-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- RERZNCLIYCABFS-UHFFFAOYSA-N harmaline Chemical compound C1CN=C(C)C2=C1C1=CC=C(OC)C=C1N2 RERZNCLIYCABFS-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- MKJIEFSOBYUXJB-HOCLYGCPSA-N (3S,11bS)-9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one Chemical compound C1CN2C[C@H](CC(C)C)C(=O)C[C@H]2C2=C1C=C(OC)C(OC)=C2 MKJIEFSOBYUXJB-HOCLYGCPSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010015995 Eyelid ptosis Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 201000003004 ptosis Diseases 0.000 description 3
- 229960005333 tetrabenazine Drugs 0.000 description 3
- AZGOVLGMSGAOMP-UHFFFAOYSA-N Aplysinopsin Natural products O=C1N(C)C(=N)N(C)C1=CC1=CNC2=CC=CC=C12 AZGOVLGMSGAOMP-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GXBMTEAMDOVNLO-PHUZRPDESA-N N1C=C(C2=CC=CC=C12)C=C1C(N(/C(/N1C)=N/C)C)=O Chemical compound N1C=C(C2=CC=CC=C12)C=C1C(N(/C(/N1C)=N/C)C)=O GXBMTEAMDOVNLO-PHUZRPDESA-N 0.000 description 2
- DPWPWRLQFGFJFI-UHFFFAOYSA-N Pargyline Chemical compound C#CCN(C)CC1=CC=CC=C1 DPWPWRLQFGFJFI-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 2
- GVONPBONFIJAHJ-UHFFFAOYSA-N imidazolidin-4-one Chemical compound O=C1CNCN1 GVONPBONFIJAHJ-UHFFFAOYSA-N 0.000 description 2
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 2
- 229960004801 imipramine Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- 229960001779 pargyline Drugs 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- RHDADYXNUCMTQG-DMLYUBSXSA-N (3s,11bs)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one;methanesulfonic acid Chemical compound CS(O)(=O)=O.C1CN2C[C@H](CC(C)C)C(=O)C[C@H]2C2=C1C=C(OC)C(OC)=C2 RHDADYXNUCMTQG-DMLYUBSXSA-N 0.000 description 1
- VLIUKLMESJCYRF-UHFFFAOYSA-N 2-imino-1,3-dimethylimidazolidin-4-one;hydroiodide Chemical compound I.CN1CC(=O)N(C)C1=N VLIUKLMESJCYRF-UHFFFAOYSA-N 0.000 description 1
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 241000264871 Dictyoceratida Species 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000243142 Porifera Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 231100000369 acute toxicity data Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB36997/76A GB1567911A (en) | 1976-09-07 | 1976-09-07 | 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone |
| CH988177A CH628046A5 (en) | 1976-09-07 | 1977-08-11 | Process for the preparation of cyclic compounds |
| US05/830,242 US4195179A (en) | 1976-09-07 | 1977-09-02 | 5-(Indol-3-ylmethylene)-1,3-dimethyl-2-methylamino-4-imidazolidinone |
| IL52895A IL52895A (en) | 1976-09-07 | 1977-09-05 | 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone derivatives,their preparation and pharmaceutica compositions containing them |
| NZ18509377A NZ185093A (en) | 1976-09-07 | 1977-09-05 | 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methyl-liminoimidazolidin-4-ones |
| FR7726835A FR2363567A1 (fr) | 1976-09-07 | 1977-09-05 | Nouveaux derives de la u-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone, leur preparation et leur application en tant que medicaments |
| DE19772740151 DE2740151A1 (de) | 1976-09-07 | 1977-09-06 | Cyclische verbindungen |
| PH20204A PH13622A (en) | 1976-09-07 | 1977-09-06 | 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolynone |
| LU78081A LU78081A1 (en:Method) | 1976-09-07 | 1977-09-06 | |
| DK395977AA DK142414B (da) | 1976-09-07 | 1977-09-06 | Analogifremgangsmåde til fremstilling af 5-(indol-3-yl-methylen)-1,3-dimethyl-2-methylimino-4-imidazolidinoner. |
| AU28585/77A AU514371B2 (en) | 1976-09-07 | 1977-09-06 | 5-(indolyl-methylene)-4-imidazolidinone derivatives |
| CA286,134A CA1096385A (en) | 1976-09-07 | 1977-09-06 | 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4- imidazolidinone |
| JP10637777A JPS5350166A (en) | 1976-09-07 | 1977-09-06 | Novel cyclic compound |
| BE180686A BE858424A (fr) | 1976-09-07 | 1977-09-06 | Composes cycliques |
| AT0639177A AT364840B (de) | 1976-09-07 | 1977-09-06 | Verfahren zur herstellung von 1,3-dimethyl-2-methylimino-4-imidazolidinonderivaten |
| ZA00775365A ZA775365B (en) | 1976-09-07 | 1977-09-06 | Cyclic compounds |
| NL7709842A NL7709842A (nl) | 1976-09-07 | 1977-09-07 | Cyclische verbindingen. |
| IT27364/77A IT1084226B (it) | 1976-09-07 | 1977-09-07 | Composti ciclici. |
| IE185077A IE45583B1 (en) | 1976-09-07 | 1977-09-07 | 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone |
| AT448480A AT363084B (de) | 1976-09-07 | 1980-09-05 | Verfahren zur herstellung von 1,3-dimethyl-2methylimino-4-imidazolidinonderivaten |
| CH540281A CH629798A5 (en) | 1976-09-07 | 1981-08-21 | Process for the preparation of cyclic compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB36997/76A GB1567911A (en) | 1976-09-07 | 1976-09-07 | 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1567911A true GB1567911A (en) | 1980-05-21 |
Family
ID=10392885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB36997/76A Expired GB1567911A (en) | 1976-09-07 | 1976-09-07 | 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4195179A (en:Method) |
| CA (1) | CA1096385A (en:Method) |
| DE (1) | DE2740151A1 (en:Method) |
| DK (1) | DK142414B (en:Method) |
| GB (1) | GB1567911A (en:Method) |
| IT (1) | IT1084226B (en:Method) |
| PH (1) | PH13622A (en:Method) |
| ZA (1) | ZA775365B (en:Method) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4570857B2 (ja) * | 2003-03-31 | 2010-10-27 | 富士フイルム株式会社 | 感光性組成物及び平版印刷版原版 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2833771A (en) * | 1958-05-06 | Process for the preparation of | ||
| US1849576A (en) * | 1926-02-13 | 1932-03-15 | Hoffmann La Roche | Glucoside of adonis vernalis l. and process for making same |
| US2364041A (en) * | 1942-01-05 | 1944-11-28 | Burton T Bush Inc | Process of preparing musk materials and product thereof |
| US2431127A (en) * | 1944-04-29 | 1947-11-18 | Gen Foods Corp | Process of treating cashew nut shell liquid |
| US3441563A (en) * | 1958-08-22 | 1969-04-29 | Bayer Ag | Process for the production of substituted pyrazolones and of monomethine dyestuffs thereof |
| US3904629A (en) * | 1970-07-17 | 1975-09-09 | American Home Prod | 4-alkyl cycloalkyl-1-piperazino-imidazolidin-2-ones or thiones |
| SU485113A1 (ru) * | 1974-02-22 | 1975-09-25 | Химико-Металлургический Институт Ан Казахской Сср | Способ получени скатилгидантоина |
-
1976
- 1976-09-07 GB GB36997/76A patent/GB1567911A/en not_active Expired
-
1977
- 1977-09-02 US US05/830,242 patent/US4195179A/en not_active Expired - Lifetime
- 1977-09-06 ZA ZA00775365A patent/ZA775365B/xx unknown
- 1977-09-06 DE DE19772740151 patent/DE2740151A1/de not_active Withdrawn
- 1977-09-06 CA CA286,134A patent/CA1096385A/en not_active Expired
- 1977-09-06 DK DK395977AA patent/DK142414B/da not_active IP Right Cessation
- 1977-09-06 PH PH20204A patent/PH13622A/en unknown
- 1977-09-07 IT IT27364/77A patent/IT1084226B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| DK142414C (en:Method) | 1981-03-23 |
| DK142414B (da) | 1980-10-27 |
| DK395977A (en:Method) | 1978-03-08 |
| PH13622A (en) | 1980-08-07 |
| DE2740151A1 (de) | 1978-03-16 |
| IT1084226B (it) | 1985-05-25 |
| CA1096385A (en) | 1981-02-24 |
| ZA775365B (en) | 1978-07-26 |
| US4195179A (en) | 1980-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4659710A (en) | 1,7-Naphthyridine derivatives and pharmaceutical compositions | |
| HUT59920A (en) | Process for producing benzodiazepinones and pharmaceutical compositions containing them as active components | |
| CY1321A (en) | 1,4-dihydropyridines their preparation and pharmaceutical compositions containing them | |
| IE47103B1 (en) | Dihydrouracils, process for their preparation and medicament containing them | |
| AU702045B2 (en) | 3-(bis-substituted-phenylmethylene)oxindole derivatives | |
| GB1568398A (en) | Triazolo pyridazine derivatives | |
| GB1571242A (en) | 3,3 - dichloro - 2 - azetidinone derivatives | |
| CN113429396A (zh) | 一种五元杂芳环衍生物及其制备方法和用途 | |
| EP0018417B1 (en) | Novel piperidine derivatives and pharmaceutical compositions containing them | |
| HU176110B (en) | Process for producing thiourea- and guanidine derivatives | |
| US4166855A (en) | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ester, and its use as a peripheral vasodilator | |
| CA1209994A (en) | 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them | |
| IL103229A (en) | Imidazolylmethyl-pyridine derivatives their preparation and pharmaceutical compositions containing them | |
| GB1567911A (en) | 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone | |
| IE53653B1 (en) | Derivatives of 4-phenyl quinazoline active on the central nervous system | |
| JPH08510477A (ja) | 新規なｎ−ベンゾイルメチル−ピペリジン類 | |
| US4514573A (en) | Isoprenylamine derivatives | |
| CA1323876C (en) | Dihydropyridine derivatives and pharmaceutical composition thereof | |
| US3957785A (en) | Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives | |
| KR880001298B1 (ko) | 벤조일-페닐-피페리딘 유도체의 제법 | |
| IE45583B1 (en) | 5-(indol-3-ylmethylene)-1,3-dimethyl-2-methylimino-4-imidazolidinone | |
| GB2101587A (en) | Methylenedioxybenzene derivatives. | |
| US4452982A (en) | Process for the preparation of nitrogen-bridgehead condensed pyrimidine compounds, and pharmaceutical compositions containing them | |
| SU862825A3 (ru) | Способ получени 3- 4-(2 -пиридил)-пиперазин-1-ил -1-(3,4,5-триметоксибензоилокси)пропана или его дигидрохлорида | |
| US4176230A (en) | 5-(6-Alkylindol-3-ylmethylene)-1,3-dimethyl-2-(methylimino)-4-imidazolidinones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |